{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:50:36Z","timestamp":1785289836859,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000926","name":"Leukaemia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000926","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010905","name":"Illumina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jmoldx.2024.04.006","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T05:28:15Z","timestamp":1721798895000},"page":"673-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5918-1692","authenticated-orcid":false,"given":"Martin","family":"Vu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-2491","authenticated-orcid":false,"given":"Koen","family":"Degeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4990-0961","authenticated-orcid":false,"given":"Georgina L.","family":"Ryland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9690-0879","authenticated-orcid":false,"given":"Ashley P.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Westerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5788-5805","authenticated-orcid":false,"given":"Maarten J.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2024.04.006_bib1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revisioin to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib2","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","article-title":"Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine","volume":"125","author":"Hunger","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib4","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/annonc\/mdw025","article-title":"Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27 Suppl 5","author":"Hoelzer","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib5","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.3390\/ijms20122929","article-title":"Next-generation sequencing in acute lymphoblastic leukemia","volume":"20","author":"Coccaro","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cancergen.2020.03.001","article-title":"Evidence-based review of genomic aberrations in B-lymphoblastic leukemia\/lymphoma: report from the Cancer Genomics Consortium Working Group for Lymphoblastic Leukemia","volume":"243","author":"Akkari","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib7","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11684-020-0759-8","article-title":"Precision medicine in acute lymphoblastic leukemia","volume":"14","author":"Pui","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","article-title":"Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Brown","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood-2021-146396","article-title":"Diagnostic utility of multimodal genomic profiling for molecular classification and MRD assessment in adult B-cell acute lymphoblastic leukemia","volume":"138 Suppl 1","author":"Ryland","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa2024534","article-title":"Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers","volume":"384","author":"Duncavage","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.53","article-title":"Acute lymphoblastic leukemia: a comprehensive review and 2017 update","volume":"7","author":"Terwilliger","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib13","series-title":"Australian Institute of Health and Welfare: Cancer Data in Australia","year":"2022"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11912-021-01086-y","article-title":"Current approaches to Philadelphia chromosome\u2013positive B-cell lineage acute lymphoblastic leukemia: role of tyrosine kinase inhibitor and stem cell transplant","volume":"23","author":"Kim","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s10198-019-01085-8","article-title":"An 8-step framework for implementing time-driven activity-based costing in healthcare studies","volume":"20","author":"da Silva Etges","year":"2019","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib16","series-title":"Guidelines for Preparing Assessments for the Medical Services Advisory Committee","year":"2021"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib17","article-title":"Implementation of whole-genome and transcriptome sequencing into clinical cancer care","volume":"6","author":"Cuppen","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-020-00905-2","article-title":"Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions","volume":"13","author":"Samra","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(21)01222-8","article-title":"KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study","volume":"398","author":"Shah","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib20","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1182\/bloodadvances.2020003482","article-title":"Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia","volume":"6","author":"Grover","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41417-021-00418-1","article-title":"Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study","volume":"29","author":"Sheykhhasan","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib22","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41409-020-0956-8","article-title":"Value and affordability of CAR T-cell therapy in the United States","volume":"55","author":"Fiorenza","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/humu.24381","article-title":"Clinical whole-genome sequencing in cancer diagnosis","volume":"43","author":"Hou","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/hematology.2022000357","article-title":"Clinical screening for Ph-like ALL and the developing role of TKIs","volume":"2022","author":"Tran","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100829","article-title":"Microcosting diagnostic genomic sequencing: a systematic review","volume":"25","author":"Santos Gonzalez","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.gim.2022.01.020","article-title":"Trio genome sequencing for developmental delay and pediatric heart conditions: a comparative microcost analysis","volume":"24","author":"Jegathisawaran","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib27","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41591-020-1072-4","article-title":"Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer","volume":"26","author":"Wong","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib28","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/2159-8290.CD-21-0126","article-title":"Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers","volume":"11","author":"Horak","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib29","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1158\/2159-8290.CD-20-1631","article-title":"Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing","volume":"11","author":"Newman","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/path.5988","article-title":"Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice","volume":"258","author":"Samsom","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.jmoldx.2024.04.006_bib31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.annonc.2023.06.011","article-title":"ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe","volume":"34","author":"Bayle","year":"2023","journal-title":"Ann Oncol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157824001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:43:33Z","timestamp":1762548213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157824001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1525157824001028"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.04.006","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2024.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}